These lesions were initially suspected to be hepatic metastases from the rectosigmoid adenocarcinoma (Figure 3). The patient underwent a hepatic metastasectomy, and histopathological analysis, along ...

Pancreatic ductal adenocarcinoma is a highly challenging disease with a 5-year survival rate of less than 5%. 1 Although most patients present with advanced disease, the best outcomes are seen in ...

Review Article Published: December 2009 Mucins in cancer: function, prognosis and therapy Donald W. Kufe Nature Reviews Cancer 9, 874–885 (2009) Cite this article ...

The bowel is split into 2 parts - the small bowel and the large bowel. The small bowel makes up most of the digestive system. This page is about cancer that begins in the small bowel. The small bowel ...

Pancreatic cancer articles from across Nature Portfolio Pancreatic cancer is a disease in which malignant cells originate in the pancreatic tissue. Cancer of the exocrine component of the pancreas ...

IM01_Subset_cluster_annotate_immune_cells.Rmd: Imports .RData object from script 03 above that includes only immune cells. In the script cells are clustered and annotated. Object that is produced and ...

Colorectal Cancer in Patients Seen at the Teaching Hospitals of Guadeloupe and Martinique Discrepancies, Similarities in Clinicopathological Features, and p53 Status ...

Cases with adenocarcinoma or carcinoma of the rectosigmoid junction or rectum (defined as the first 15 cm from the anal opening), with known familial adenomatous polyposis, ulcerative colitis, or ...

Background and aims Mechanisms of the progression from Barrett's oesophagus to oesophageal adenocarcinoma (OA) are not fully understood. Bile acids may have an important role in this progression. This ...

Most colon cancers are assumed to have a premalignant adenomatous polyp phase, therefore colonoscopic detection and polypectomy provides the opportunity for cancer prevention. Some patients who have ...

AbstractActivating mutations in KRAS drive tumorigenesis in pancreatic ductal adenocarcinoma (PDAC), promoting tumor cell proliferation and contributing to an immunosuppressive tumor microenvironment, ...